CAS: 24897-50-5; Uracil-5-D

该化合物是一个化学化合物,其特点是其具有湿度环结构,由六人组成,含有1号位置和3号位置的两个氮原子的热循环环,该化合物具有2号位置和4号位置的两个碳基组(C=O),有助于其狄克酮的性质; 分子中存在一个或一个以上的氢原子(用"d"表示),表明分子中有一个或一个以上的氢原子已被氢取代,而氢是一种稳定的同位素,可以用于各种应用,包括代谢研究中的痕量研究;该化合物通常用于生物化学和制药研究,特别是涉及核酸和酶相互作用的研究,其溶剂和再活性可因溶剂和条件而不同,使其在合成有机化学化学中成为一种灵敏性化合物.应查询安全数据,用于处理和储存,如所有化学物质.

结构式图片

MSDS等安全信息

    上下游产品

    CAS号696-07-1 5-碘尿嘧啶 | CAS号66-22-8 尿嘧啶 | CAS号24897-55-0 尿嘧啶-D4

    合成工艺路线路线简述

    • 合成目标产物 Uracil-5-D1 主要起始原料 Uracil
    • (文献来源)合成步骤主要原料 Uracil
    📜1,3,5-Trideuterio-1H-Pyrimidine-2,4-Dione 在 水体系中,获得 <5-2H>Uracil
    参考文献:Nucleic Acid Bases Studied By Matrix Isolation Vibrational Spectroscopy: Uracil And Deuterated Uracils
    标题:Nucleic Acid Bases Studied By Matrix Isolation Vibrational Spectroscopy: Uracil And Deuterated Uracils
    摘要:
    Doi:10.1016/0584-8539(84)80073-2

    专利信息


    专利号:US-8618279-B2
    优先权日:2009-01-15
    标 题 :Synthesis of 2′,3′— and 3′,5′—cyclic phosphate mono-and oligonucleotides
    发明人:LAIKHTER ANDREI; SRIVASTAVA SURESH CHANDRA; SRIVASTAVA NAVEEN
    权利人:LAIKHTER ANDREI; SRIVASTAVA SURESH CHANDRA; SRIVASTAVA NAVEEN; CHEMGENES CORP
    摘要:The invention provides a novel method for the chemical synthesis of 2′,3′-cyclic phosphate and phosphorothioate of mono and terminated oligonucleotides synthesis. The invention also provides a novel method of for the chemical synthesis of 2′,3′- and 3′,5′-cyclic phosphate and phosphorothioate mononucleotide nucleotides. The process is based on quick and efficient cyclization of phosphoramidate moiety and neighboring hydroxyl group. The present invention is directed towards the synthesis of high purity DNA and RNAs, specifically to introduce cyclic phosphate at 3′-end of oligonucleotides. Such DNA and RNA's have extensive application in therapeutics, diagnostics, drug design, and selective inhibition of an RNA sequence within cellular environment, in pre-tRNA cleavage and in ribozyme ligation. The 2′,3′-cyclic phosphate nucleosides are involved in a vast number of applications in molecular biology in general and mammalian cells in particular. The invention also envisions providing kits comprising at least one composition disclosed in the present invention.

    专利号:US-2024287520-A1
    优先权日:2021-06-30
    标题:Method for synthesis of linkage modified oligomeric compounds
    发明人:RODRIGUEZ ANDREW A
    权利人:IONIS PHARMACEUTICALS INC
    摘要:The present disclosure provides methods of synthesizing modified oligonucletodies and oligomeric compounds (including oligomeric compounds that are antisense agents or portions thereof) comprising a modified oligonucleotide having at least one modified internucleoside linking group. In certain embodiments, the present disclosure provides stabilized formulations of certain sulfonyl azides for use in the synthesis of olignonucleotides comprising one or more sulfonyl phosphoramidate linkages. Some embodiments provide stabilized compositions of high energy reagents that may be used in the synthesis of modified oligonucleotides, allowing for safe process scale preparation thereof.

    专利号:US-2010143980-A1
    优先权日:2007-02-22
    标题:Synthesis of novel xylosides and potential uses thereof
    发明人:BALAGURUNATHAN KUBERAN; MANIVANNAN ETHIRAJAN; XYLOPHONE V VICTOR; TRAN VY MY; NGUYEN KHIEM
    权利人:BALAGURUNATHAN KUBERAN; MANIVANNAN ETHIRAJAN; XYLOPHONE V VICTOR; TRAN VY MY; NGUYEN KHIEM
    摘要:The present invention includes a xyloside for use in inducing synthesis of a glycosaminoglycan in a cell, the xyloside having a chemical structure of one of Formula (1), Formula (2), Formula (3), Formula (4), Formula (5), Formula (6), Formula (7), Formula (8), Formula (9), or Formula (10) as shown herein. Also, the present invention includes a method of making a xyloside for use in inducing synthesis of a glycosaminoglycan in a cell, wherein the method is performed with “Clickâ€? chemistry. Additionally, the present invention includes a method of administering a xyloside so as to induce synthesis of a glycosaminoglycan in a cell.

    专利号:US-10167308-B2
    优先权日:2013-09-14
    标题:Highly efficient synthesis of long RNA using reverse direction approach
    发明人:SRIVASTAVA SURESH C; SRIVASTAVA NAVEEN P
    权利人:CHEMGENES CORP
    摘要:The present invention relates to novel process of reverse 5′→3′ directed synthesis of RNA oligomers in the range of about 100-mer to about 200-mer has been developed and disclosed. Using that method demonstrated high quality RNA synthesis with coupling efficiency approaching 99%.

    专利号:US-11542269-B2
    优先权日:2018-01-03
    标 题:Prins reaction and compounds useful in the synthesis of halichondrin macrolides and analogs thereof
    发明人:CHOI HYEONG-WOOK; FANG FRANCIS G
    权利人:EISAI R&D MAN CO LTD
    摘要:The invention provides methods utilizing Prins reaction in the preparation of compounds that may be useful as intermediates in the synthesis of halichondrin macrolides and analogs thereof. The invention also provides compounds that may be useful as intermediates in the synthesis of a halichondrin macrolides and methods for preparing the same.

    专利号:WO-2024201393-A1
    优先权日:2023-03-29
    标 题:Methods for the synthesis of nucleoside analogues and nucleosides analogues derived therefrom
    发明人:BRITTON ROBERT; Muir Garrett; ANKETELL MATTHEW JAMES; HUXLEY COHAN; BAIKABI SUPING
    权利人:UNIV FRASER SIMON
    摘要:The present invention relates to methods for the synthesis of nucleoside analogues. More specifically, the present invention relates to methods for the synthesis of C4' substituted nucleoside analogues via the reaction of a soft nucleophile with a halohydrin ketone.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Ishikawa T, Higuchi K, Kubota T, Seki K, Ohta H, Yoshida T, Kamimura T. [Multiple liver metastases due to sigmoid colon cancer successfully treated by degradable starch microspheres (DSM)-TAE, radiofrequency ablation therapy, and Uzel/UFT]. Gan To Kagaku Ryoho. 2010 Feb;37(2):335–8.
    摘要:Kitaguchi H, Nakai T, Yoshifuji T, Ueda K, Tokoro T, Hida J, Okuno K. [A case of complete response after treatment with UFT and leucovorin for synchronous multiple liver metastases of rectal cancer]. Gan To Kagaku Ryoho. 2010 Feb;37(2):339–42.
    参考文献:10.1007/s11596-010-0112-6
    摘要:Zhai R, Wang G, Cai K, Tao K, Xu F, Zhang W, Wang Z. Epigenetic regulation of the ERbeta gene on the estrogen signal transfection pathway in colon cancer cells. J Huazhong Univ Sci Technolog Med Sci. 2010 Feb;30(1):69–74. doi: 10.1007/s11596-010-0112-6.
    参考文献:10.1007/s10266-009-0118-3
    摘要:Niimi M, Firth NA, Cannon RD. Antifungal drug resistance of oral fungi. Odontology. 2010 Feb;98(1):15–25. doi: 10.1007/s10266-009-0118-3.
    参考文献:10.1007/bf00425416
    摘要:Gupta RS, Kumar HD. The effect of maleic hydrazide on growth and mutation of a blue-green alga. Arch Mikrobiol. 1970;70(4):330–9. doi: 10.1007/bf00425416.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知